Assessment of potential particulate contamination in intravenous solutions in an adult intensive care unit: a targeted correlation analysis.

IF 1.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Yvonne Remane, Annett Frisch, Johanna Krainz, Jan Vogel, Donald Ranft, Julia Borella, Vincent-Christoph Klaus, Sirak Petros, Thilo Bertsche
{"title":"Assessment of potential particulate contamination in intravenous solutions in an adult intensive care unit: a targeted correlation analysis.","authors":"Yvonne Remane, Annett Frisch, Johanna Krainz, Jan Vogel, Donald Ranft, Julia Borella, Vincent-Christoph Klaus, Sirak Petros, Thilo Bertsche","doi":"10.1136/ejhpharm-2025-004523","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Intravenous drug administration is essential in intensive care treatment. However, the risk of particulate contamination in infusion solutions during treatment is often underestimated.</p><p><strong>Methods: </strong>Residual amounts of infusion solutions prepared and administered at the adult intensive care unit were examined for visible and subvisible particles according to the recommendations of the European Pharmacopoeia monographs 2.9.19 and 2.9.20.</p><p><strong>Results: </strong>Samples from 169 infusion solutions were collected, 149 of which could be analysed. The Pharmacopoeia requirements for visible particles were not fulfilled in 42.9% (n=64/149) of the samples, while the requirements for subvisible particles were not met in 4.7% (n=7/149). A specific correlation between the pharmaceutical drugs or within the infusion set (bottle vs connected infusion line) and particulate contamination was not possible as the sample was too small for a correlation analysis. A Spearman rho analysis showed no correlation between particle contamination and administration mode (subvisible (10 µm): p=0.969, r=-0.005; subvisible (25 µm): p=0.834, r=-0.026; visible: p=0.711, r=-0.047) and particle contamination and dosage form (subvisible (10 µm): p=0.291, r=-0.092; subvisible (25 µm): p=0.513, r=0.057; visible: p=0.415, r=0.071).</p><p><strong>Conclusions: </strong>This study showed that residuals of intravenously administered solutions have particulate contaminations. A specific causal factor was not identified.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of hospital pharmacy : science and practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2025-004523","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Intravenous drug administration is essential in intensive care treatment. However, the risk of particulate contamination in infusion solutions during treatment is often underestimated.

Methods: Residual amounts of infusion solutions prepared and administered at the adult intensive care unit were examined for visible and subvisible particles according to the recommendations of the European Pharmacopoeia monographs 2.9.19 and 2.9.20.

Results: Samples from 169 infusion solutions were collected, 149 of which could be analysed. The Pharmacopoeia requirements for visible particles were not fulfilled in 42.9% (n=64/149) of the samples, while the requirements for subvisible particles were not met in 4.7% (n=7/149). A specific correlation between the pharmaceutical drugs or within the infusion set (bottle vs connected infusion line) and particulate contamination was not possible as the sample was too small for a correlation analysis. A Spearman rho analysis showed no correlation between particle contamination and administration mode (subvisible (10 µm): p=0.969, r=-0.005; subvisible (25 µm): p=0.834, r=-0.026; visible: p=0.711, r=-0.047) and particle contamination and dosage form (subvisible (10 µm): p=0.291, r=-0.092; subvisible (25 µm): p=0.513, r=0.057; visible: p=0.415, r=0.071).

Conclusions: This study showed that residuals of intravenously administered solutions have particulate contaminations. A specific causal factor was not identified.

成人重症监护病房静脉溶液中潜在颗粒污染的评估:目标相关性分析。
背景:静脉给药在重症监护治疗中是必不可少的。然而,在治疗过程中,输液液中颗粒污染的风险往往被低估。方法:根据欧洲药典专著2.9.19和2.9.20的建议,对成人重症监护病房配制和给药的输液液残留量进行可见和不可见颗粒检查。结果:共收集到169份输液液样品,其中149份可进行分析。42.9% (n=64/149)的样品不符合药典要求,4.7% (n=7/149)的样品不符合药典要求。由于样品太小,无法进行相关性分析,因此不可能确定药物或输液器内(瓶与连接的输液管)与颗粒污染之间的特定相关性。Spearman rho分析显示,颗粒污染与给药方式(subvisible(10µm))没有相关性:p=0.969, r=-0.005;Subvisible(25µm): p=0.834, r=-0.026;可见:p=0.711, r=-0.047),颗粒污染和剂型(亚可见(10µm): p=0.291, r=-0.092;Subvisible(25µm): p=0.513, r=0.057;可见:p=0.415, r=0.071)。结论:本研究显示静脉注射溶液的残留物有微粒污染。具体的原因尚未确定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.40
自引率
5.90%
发文量
104
审稿时长
6-12 weeks
期刊介绍: European Journal of Hospital Pharmacy (EJHP) offers a high quality, peer-reviewed platform for the publication of practical and innovative research which aims to strengthen the profile and professional status of hospital pharmacists. EJHP is committed to being the leading journal on all aspects of hospital pharmacy, thereby advancing the science, practice and profession of hospital pharmacy. The journal aims to become a major source for education and inspiration to improve practice and the standard of patient care in hospitals and related institutions worldwide. EJHP is the only official journal of the European Association of Hospital Pharmacists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信